BioMarin Pharmaceutical (BMRN)
|
55.01
+0.22 (+0.40%)
|
|
|
|
BMRN analyst ratings
Market Data powered by QuoteMedia. Data delayed 15 minutes unless otherwise indicated. Filings and Fundamentals by Morningstar, Insiders by Vickers (USA) and SEDI(CDN), analyst ratings by Zacks.
BMRN price and earnings targets
Market Data powered by QuoteMedia. Data delayed 15 minutes unless otherwise indicated. Filings and Fundamentals by Morningstar, Insiders by Vickers (USA) and SEDI(CDN), analyst ratings by Zacks.
Special Offers
BMRN earnings
Date
Actual
Expected
Prev Yr Qtr
10/25/2012
-0.04
-0.20
-0.14
8/1/2012
-0.27
-0.21
-0.05
4/26/2012
-0.21
-0.14
-0.04
BioMarin Pharmaceutical (BMRN) Upgrades
Date
Analyst
Old Rating
New Rating
09/01/2010
Morgan Joseph
Hold
Buy
07/31/2009
Wedbush Morgan
Undeperform
Neutral
01/07/2009
Benchmark Capital
Hold
Buy
11/21/2008
Citi
Hold
Buy
07/25/2008
UBS
Neutral
Buy
10/02/2006
Robert W. Baird
Outperform
N/ A
BioMarin Pharmaceutical (BMRN) Downgrades
Date
Analyst
Old Rating
New Rating
12/02/2010
Update - UBS
Buy
Neutral
12/02/2010
UBS
Buy
Neutral
11/01/2010
Morgan Joseph
Buy
Hold
02/08/2010
Brean Murray
Buy
Hold
01/08/2010
Morgan Joseph
Buy
Hold
10/15/2008
Benchmark Capital
Buy
Hold
BioMarin Pharmaceutical (BMRN) New Coverage
Date
Analyst
Rating
08/07/2012
Lazard Capital
Buy
03/26/2012
Canaccord Genuity
Buy
10/18/2010
Gleacher & Co
Neutral
09/24/2009
FTN Equity
Buy
04/21/2009
Morgan Joseph
Buy
03/31/2009
Thomas Weisel
Marketweight
